Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Maravai Lifesciences Holdings (MRVI) Amortization - Deferred Charges (2020 - 2021)

Maravai Lifesciences Holdings has reported Amortization - Deferred Charges over the past 2 years, most recently at $900000.0 for Q3 2021.

  • Quarterly results put Amortization - Deferred Charges at $900000.0 for Q3 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $900000.0 (down 95.26% YoY), and the annual figure for FY2020 was $19.0 million, changed.
  • Amortization - Deferred Charges for Q3 2021 was $900000.0 at Maravai Lifesciences Holdings, down from $19.0 million in the prior quarter.
  • Over the last five years, Amortization - Deferred Charges for MRVI hit a ceiling of $19.0 million in Q1 2020 and a floor of $900000.0 in Q3 2021.